abstract |
The present invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising these compounds, the use of these compounds in the treatment of disorders or diseases mediated by MDM2 and/or MDM4 activity, and in the treatment of MDM2 and/or Methods of using these compounds in disorders or diseases mediated by or MDM4 activity, and combinations comprising these compounds. |